Walgreens Boots Alliance, Inc.: Konsensus der Analysten und Kursziel | A12HJF | US9314271084 | MarketScreener (2024)

WALGREENS BOOTS ALLIANCE, INC.

Zu einer Liste hinzufügen

Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein

EinloggenRegistrieren

Aktien

A12HJF

US9314271084

0LSZ

Markt geschlossen - London S.E.

Andere Börsenplätze

17:41:58 13.09.2024
% 5 Tage % 1. Jan.
9,150 USD -11,00% Walgreens Boots Alliance, Inc.: Konsensus der Analysten und Kursziel | A12HJF | US9314271084 | MarketScreener (2) +4,57% -64,78%
13.09. KKR kauft 11,6 Millionen Aktien von BrightSpring von Walgreens MT
13.09. Walgreens Boots Alliance zahlt 106,8 Millionen Dollar zur Beilegung von Vorwürfen wegen falscher Angaben MT

Entwicklung des mittleren Kursziels: Walgreens Boots Alliance, Inc.

Entwicklung des Kursziels: Walgreens Boots Alliance, Inc.

Änderungen der Analystenempfehlungen: Walgreens Boots Alliance, Inc.

35ecadb746c7.aw2Otzcg902v4aaI2I6qArsA0-4KeqprVyKKxdlNycs.W0j9wFtWvyDCrsjsru3SSdg4ht9bE_4yZUe5tJUFkIoue9fzeVXAC9uD7w~0ccd65c1123cc16cd1fafb57c771c558

Empfehlungen der Analysten: Walgreens Boots Alliance, Inc.

WALGREENS BOOTS ALLIANCE, INC. : TD Cowen bleibt neutral ZM
WALGREENS BOOTS ALLIANCE, INC. : Bewertung von Leerink Partners kaufen ZM
WALGREENS BOOTS ALLIANCE, INC. : Evercore ISI bekräftigt seine neutrale Bewertung ZM
WALGREENS BOOTS ALLIANCE, INC. : Morgan Stanley bekräftigt seine Verkaufsbewertung ZM
WALGREENS BOOTS ALLIANCE, INC. : TD Cowen bekräftigt seine Kaufempfehlung ZM
WALGREENS BOOTS ALLIANCE, INC. : HSBC behält seine Kaufempfehlung bei ZM
CVS Omnicare-Mitarbeiter in Las Vegas stimmen für den Beitritt zur neuen Gewerkschaft RE
WALGREENS BOOTS ALLIANCE, INC. : Bewertung von Morgan Stanley zum Kaufen erhalten ZM
WALGREENS BOOTS ALLIANCE, INC. : Bewertung von Truist Securities kaufen ZM
WALGREENS BOOTS ALLIANCE, INC. : RBC Capital Markets bekräftigt seine neutrale Bewertung ZM
WALGREENS BOOTS ALLIANCE, INC. : UBS klebt neutral ZM
Top Midday Stories: Bankman-Fried wird zu 25 Jahren Haft verurteilt; Home Depot erwirbt SRS Distribution; Walgreens senkt Ausblick für das Geschäftsjahr 2024; Analyst rät zu Short MicroStrategy; Kanadische Schulbehörden verklagen Social Media Plattformen; Eli Lilly Medikament zur Gewichtsreduktion wird knapp MT
WALGREENS BOOTS ALLIANCE, INC. : BofA Securities gibt eine Verkaufsbewertung ab ZM
WALGREENS BOOTS ALLIANCE, INC. : Erhält eine Verkaufsbewertung von Morgan Stanley ZM
WALGREENS BOOTS ALLIANCE, INC. : Leerink Partners gibt eine neutrale Bewertung ab ZM
WALGREENS BOOTS ALLIANCE, INC. : Leerink Partners klebt neutral ZM
WALGREENS BOOTS ALLIANCE, INC. : HSBC senkt Bewertung auf Verkaufen ZM
WALGREENS BOOTS ALLIANCE, INC. : Deutsche Bank Securities klebt neutral ZM
UBS belässt Walgreens Boots Alliance auf 'Neutral' DP
WALGREENS BOOTS ALLIANCE, INC. : Vom Kauf zur neutralen Bewertung von HSBC ZM
WALGREENS BOOTS ALLIANCE, INC. : Von Neutral zu Kaufen bei JPMorgan Chase ZM
WALGREENS BOOTS ALLIANCE, INC. : RBC Capital Markets bleibt neutral ZM
WALGREENS BOOTS ALLIANCE, INC. : UBS bekräftigt seine neutrale Bewertung ZM
WALGREENS BOOTS ALLIANCE, INC. : Mizuho Securities bekräftigt seine neutrale Bewertung ZM
WALGREENS BOOTS ALLIANCE, INC. : JPMorgan Chase bekräftigt seine neutrale Bewertung ZM

Mehr Empfehlungen

Zu einer Liste hinzufügen

Zu einer Liste hinzufügen

0 ausgewählt

Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein

EinloggenRegistrieren

Analystenempfehlungen Verlauf d. Empfehlungen 4M Streuung bei den Analystenmeinungen Streuung beim Kursziel Ziel/ Preisdifferenz

JD HEALTH INTERNATIONAL INC.

+44,41%

+25,65%

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

+77,73%

CLICKS GROUP LIMITED

-6,94%

CORPORATIVO FRAGUA, S.A.B. DE C.V.

- - - +49,02%

NAHDI MEDICAL COMPANY

+10,53%

YIFENG PHARMACY CHAIN CO., LTD.

+120,65%

WELCIA HOLDINGS CO., LTD.

+14,10%

REDCARE PHARMACY NV

+26,60%
Durchschnitt +40,19%
Gewichteter Durchschnitt nach Marktkapitalisierung +39,44%

Gesamten Branchenkonsens anzeigen

Analystenschätzungen

Verkaufen

Walgreens Boots Alliance, Inc.: Konsensus der Analysten und Kursziel | A12HJF | US9314271084 | MarketScreener (12)

Kaufen

Durchschnittl. Empfehlung

HALTEN

Anzahl Analysten

19

Letzter Schlusskurs

9,210USD

Mittleres Kursziel

12,43USD

Abstand / Mittleres Kursziel

+34,98%

Höchstes Kursziel

23,00USD

Abstand / Höchstes Kursziel

+149,73%

Niedrigstes Kursziel

7,000USD

Abstand / Niedrigstes Kursziel

-24,00%

Einzelheiten zum Analystenkonsens

Verlauf des Kursziels (Vergangene 18 Monate)

Analysten, die das Unternehmen abdecken

TD Cowen
Leerink Partners
Evercore ISI
Morgan Stanley
HSBC
Truist Securities
RBC Capital Markets
UBS
BofA Securities
Deutsche Bank Securities
JPMorgan Chase
Mizuho Securities
Credit Suisse
Barclays
Loop Capital
Cowen
Argus
Baird
J.P. Morgan Chase
Goldman Sachs

Ratings

Trading Rating

Investment Rating

ESG Refinitiv

Mehr Ratings

Gewinnrevisionen

Revisionen der Schätzungen

Quartalsgewinne, Abweichungsrate

Unternehmenstermine

  1. Börse
  2. Aktien
  3. A12HJF Aktie
  4. A12HJF Aktie
  5. Schätzungen Walgreens Boots Alliance, Inc.
Profitieren Sie von unseren kostenlosen Inhalten, um Ihre Investitionen abzusichern und deren Performance zu steigern Meine Investitionen sichern

Walgreens Boots Alliance, Inc.: Konsensus der Analysten und Kursziel | A12HJF | US9314271084 | MarketScreener (13)

"); for (var element in ICConf) { if (document.getElementById("zpp"+element)) { document.getElementById("zpp"+element).innerHTML = ""; } } InvestingChannelQueue.push(function() { ic_page = InvestingChannel.UAT.Run("5c5a75c3-8896-4592-98f8-dc06e6fdcc56"); }); } gaEvent('adspv', 'InvestingChannel_v2', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'de_DE');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '41674269');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });
Walgreens Boots Alliance, Inc.: Konsensus der Analysten und Kursziel | A12HJF | US9314271084 | MarketScreener (2024)

FAQs

What is the difference between Walgreens and Walgreens Boots Alliance? ›

Walgreens Boots Alliance, Inc.

(WBA) is an American multinational holding company headquartered in Deerfield, Illinois, which owns the retail pharmacy chains Walgreens in the US and Boots in the UK, as well as several pharmaceutical manufacturing and distribution companies.

Is Walgreens Boots Alliance a good company to work for? ›

Do people recommend working at Walgreens Boots Alliance? Overall, 48% of employees would recommend working at Walgreens Boots Alliance to a friend. This is based on 2,141 anonymously submitted reviews on Glassdoor. How do job seekers rate their interview experience at Walgreens Boots Alliance?

What is the forecast for Walgreens Boots Alliance? ›

Based on short-term price targets offered by 15 analysts, the average price target for Walgreens Boots Alliance comes to $12.13. The forecasts range from a low of $7.00 to a high of $22.00. The average price target represents an increase of 36.14% from the last closing price of $8.91.

What is the strategy of Walgreens Boots Alliance? ›

Walgreens Boots Alliance Inc (NASDAQ:WBA) faces a complex financial landscape with significant restructuring costs and legal settlements impacting its financial statements. The company's strategic focus on healthcare services and omnichannel retailing positions it for potential growth amidst industry shifts.

What brands are under the Walgreens Boots Alliance? ›

WBA employs more than 331,000 people and has a presence in eight countries through its portfolio of consumer brands: Walgreens, Boots, Duane Reade, the No7 Beauty Company and Benavides in Mexico.

Is Walgreens Boots Alliance a good buy? ›

Walgreens Boots Alliance's analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

What is the price target for WBA in 2025? ›

According to analysts, WBA price target is 11.64 USD with a max estimate of 22.00 USD and a min estimate of 7.00 USD.

Who is the CEO of Walgreens Boots Alliance? ›

Chief Executive Officer, Walgreens Boots Alliance, Inc.

What is the credit rating of Walgreens Boots? ›

We believe material strategic changes, limited cash flow generation, and large maturities in coming years are key risks to the business. Therefore, we lowered our ratings on Walgreens two notches to 'BB' from 'BBB-', putting it in the speculative-grade category.

What is the business model of Walgreens Boots Alliance? ›

WBA has a global portfolio of healthcare-focused investments. Our equity method investments enable us to further extend our healthcare solutions and convenience offering to the communities we serve. Propelling our company and the industry forward takes passion and expertise. Meet the people leading the way.

What is the future plan of the Walgreens Boots Alliance? ›

Boots Transformation Plan

During 2023, Walgreens also revealed plans to close 300 U.K. Boots stores over the following 12 months as it said that it was looking to consolidate the business via a transformation plan, which has pivoted towards specialist services and beauty.

What are the values of Walgreens Boots Alliance? ›

We take our aim of inspiring a healthier and happier world seriously and this is reflected in our core values of Trust, Care, Innovation, Partnership and Dedication. WBA is a global family of trusted companies with a reputation for doing the right thing.

Is Alliance Rx the same as Walgreens? ›

Walgreens Specialty Pharmacy and Walgreens Mail Service will be the new names for AllianceRx Walgreens Pharmacy and Walgreens community-based specialty pharmacies, effective August 1, 2024.

How did Walgreens become Walgreens Boots Alliance? ›

Walgreens acquires a 45 percent stake in Alliance Boots, taking the first step in the strategic partnership to create the first global pharmacy- led, health and wellbeing enterprise. Walgreens and Alliance Boots form Walgreens Boots Alliance Development joint venture in Bern, Switzerland.

What are the divisions of Walgreens Boots Alliance? ›

In order to best leverage the size, scale and expertise of our large company, we operate a number of global, cross-divisional functions.
  • U.S. Retail Pharmacy Segment. ...
  • International Segment. ...
  • U.S. Healthcare Segment. ...
  • No7 Beauty Company.

What other advantage did Walgreens realize with the eventual merger with Alliance Boots? ›

What other advantage did Walgreens's realize with the eventual merger with Alliance Boots? It strengthened Walgreens ' s existing business by increasing the company ' s market position and therefore bargaining power with drug companies. It capitalized on Walgreens ' s capabilities and competencies.

Top Articles
Latest Posts
Article information

Author: Chrissy Homenick

Last Updated:

Views: 6554

Rating: 4.3 / 5 (54 voted)

Reviews: 93% of readers found this page helpful

Author information

Name: Chrissy Homenick

Birthday: 2001-10-22

Address: 611 Kuhn Oval, Feltonbury, NY 02783-3818

Phone: +96619177651654

Job: Mining Representative

Hobby: amateur radio, Sculling, Knife making, Gardening, Watching movies, Gunsmithing, Video gaming

Introduction: My name is Chrissy Homenick, I am a tender, funny, determined, tender, glorious, fancy, enthusiastic person who loves writing and wants to share my knowledge and understanding with you.